Yersinia Species (Including Plague)

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases

Volumn 2, Issue , 2014, Pages 2607-2618

  Mead, Paul S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Bioterrorism; Black Death; Bubo; Erythema nodosum; HLA B27; Mesenteric lymphadenitis; Plague; Pseudoappendicitis; Reactive arthritis; Sacroiliitis; Yersinia enterocolitica; Yersinia pestis; Yersinia pseudotuberculosis

Indexed keywords

EID: 84924463483     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-4801-3.00231-9     Document Type: Chapter

References (226)

1. Euzeby JP List of Prokaryotic Names with Standing in Nomenclature January 18, 2012. Available at, Accessed December 1, 2012. http://www.bacterio.net.
2. Perry RD, Fetherston JD Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 1997, 10:35-66.
3. McGovern T, Friedlander A Plague. Textbook of Military Medicine. Part I 1997, 479-502. Office of the Surgeon General, United States Army, Falls Church, VA. F. Sidell, E. Takafuji, D. Franz (Eds.).
4. McNeill WH Plague and Peoples 1998, Anchor Press, Garden City, NY.
5. Cohn SK The Black Death: end of a paradigm. Am Hist Rev 2002, 107:703-738.
6. Drancourt M, Houhamdi L, Raoult D Yersinia pestis as a telluric, human ectoparasite-borne organism. Lancet Infect Dis 2006, 6:234-241.
7. Wiechmann I, Grupe G Detection of Yersinia pestis DNA in two early medieval skeletal finds from Aschheim (Upper Bavaria, 6th century A.D.). Am J Phys Anthropol 2005, 126:48-55.
8. Eisen RJ, Bearden SW, Wilder AP, et al. Early-phase transmission of Yersinia pestis by unblocked fleas as a mechanism explaining rapidly spreading plague epizootics. Proc Natl Acad Sci U S A 2006, 103:15380-15385.
9. Butler T Plague and Other Yersinia Infections 1983, Plenum, New York.
10. Chanteau S, Ratsifasoamanana L, Rasoamanana B, et al. Plague, a reemerging disease in Madagascar. Emerg Infect Dis 1998, 4:101-104.
11. Stenseth NC, Atshabar BB, Begon M, et al. Plague: past, present, and future. PLoS Med 2008, 5:e3.
12. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. JAMA 2000, 283:2281-2290.
13. Centers for Disease Control and Prevention and the Animal Plant Health Inspection Agency National Select Agent Registry Available at, Accessed January 15, 2013. http://www.selectagents.gov.
14. U.S.Department of Health and Human Services 42 CFR Part 73. Possession, use, and transfer of select agents and toxins; biennial review. Fed Register 2012, 77:194.
15. Centers for Disease Control and Prevention, National Center for Infectious Diseases Division of Vector-Borne Infectious Diseases, World Health Organization, World Health Organization. Division of Emerging and Other Communicable Diseases Surveillance and Control. Laboratory Manual of Plague Diagnostic Tests 2000, Centers for Disease Control and Prevention, Atlanta, GA.
16. Achtman M, Zurth K, Morelli G, et al. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A 1999, 24:14043-14048.
17. Zhou D, Han Y, Yang R Molecular and physiological insights into plague transmission, virulence and etiology. Microbes Infect 2006, 8:273-284.
18. Parkhill J, Wren BW, Thompson NR, et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 2001, 413:523-527.
19. Hinnebusch BJ The evolution of flea-borne transmission in Yersinia pestis. Curr Issues Mol Biol 2005, 7:197-212.
20. Prentice MB, James KD, Parkhill J, et al. Yersinia pestis pFra shows biovar-specific differences and recent common ancestry with a Salmonella enterica serovar Typhi plasmid. J Bacteriol 2001, 183:2586-2594.
21. Fabrega A, Vila J Yersinia enterocolitica: pathogenesis, virulence, and antimicrobial resistance. Enferm Infecc Microbiol Clin 2012, 30:24-32.
22. Achtman M, Morelli G, Zhu P, et al. Microevolution and history of the plague bacillus, Yersinia pestis. Proc Natl Acad Sci U S A 2004, 101:17837-17842.
23. Drancourt M, Signoli M, Dang LV, et al. Yersinia pestis Orientalis in remains of ancient plague patients. Emerg Infect Dis 2007, 13:332-333.
24. Gage KL Plague surveillance. Plague Manual: Epidemiology, Distribution, Surveillance and Control 1999, 135-166. World Health Organization, Geneva.
25. World Health Organization Human plague in 2002 and 2003. Wkly Epidemiol Rec 2004, 79:301-306.
26. Cabanel N, Leclercq A, Chenal-Francisque V, et al. Plague outbreak in Libya, 2009, unrelated to plague in Algeria. Emerg Infect Dis 2013, 19:230-236.
27. Boisier P, Rahalison L, Rasolomaharo M, et al. Epidemiological features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar. Emerg Infect Dis 2002, 8:311-316.
28. Eisen RJ, Gage KL Adaptive strategies of Yersinia pestis to persist during inter-epizootic and epizootic periods. Vet Res 2009, 40:01.
29. von Reyn CF, Barnes AM, Weber NS, et al. Bubonic plague from exposure to a rabbit: a documented case, and a review of rabbit-associated plague cases in the United States. Am J Epidemiol 1976, 104:81-87.
30. Gage KL, Dennis DT, Orloski KA, et al. Cases of cat-associated plague in the western U.S., 1977-1998. Clin Infect Dis 2000, 30:893-900.
31. Gould LH, Pape J, Ettestad P, et al. Dog-associated risk factors for human plague. Zoonoses Public Health 2008, 55:448-454.
32. Bin Saeed AA, Al-Hamdan NA, Fontaine RE Plague from eating raw camel liver. Emerg Infect Dis 2005, 11:1456-1457.
33. Centers for Disease Control and Prevention Fatal human plague-Arizona and Colorado, 1996. MMWR Morb Mortal Wkly Rep 1997, 46:617-620.
34. Kaufmann AF, Boyce JM, Martone WJ Trends in human plague in the United States. J Infect Dis 1980, 141:522-524.
35. Mann JM, Martone WJ, Boyce JM, et al. Endemic human plague in New Mexico: risk factors associated with infection. J Infect Dis 1979, 140:397-401.
36. Schotthoefer AM, Eisen RJ, Kugeler KJ, et al. Changing socioeconomic indicators of human plague, New Mexico, USA. Emerg Infect Dis 2012, 18:1151-1154.
37. Centers for Disease Control and Prevention Imported plague-New York City, 2002. MMWR Morb Mortal Wkly Rep 2003, 52:725-728.
38. Wong D, Wild MA, Walburger MA, et al. Primary pneumonic plague contracted from a mountain lion carcass. Clin Infect Dis 2009, 49:e33-e38.
39. Centers for Disease Control and Prevention Fatal laboratory-acquired infection with an attenuated Yersinia pestis strain-Chicago, Illinois, 2009. MMWR Morb Mortal Wkly Rep 2011, 60:201-205.
40. Quenee LE, Hermanas TM, Ciletti N, et al. Hereditary hemochromatosis restores the virulence of plague vaccine strains. J Infect Dis 2012, 206:1050-1058.
41. Butler T A clinical study of bubonic plague: observations on the 1970 Vietnam epidemic with emphasis on coagulation studies, skin histology and electrocardiograms. Am J Med 1972, 53:268-276.
42. Dennis D, Meier F Plague. Pathology of Emerging Infections 1997, 21-47. ASM Press, Washington, DC. C.R. Horsburgh, A.M. Nelson (Eds.).
43. Butler T, Bell WR, Nguyen NL, et al. Yersinia pestis infection in Vietnam, I. Clinical and hematological aspects. J Infect Dis 1974, 129(suppl):S78-S84.
44. Hull HF, Montes JM, Mann JM Plague masquerading as gastrointestinal illness. West J Med 1986, 145:485-487.
45. Hull HF, Montes JM, Mann JM Septicemic plague in New Mexico. J Infect Dis 1987, 155:113-118.
46. Crook LD, Tempest B Plague: a clinical review of 27 cases. Arch Intern Med 1992, 152:1253-1256.
47. Wu L-T A Treatise on Pneumonic Plague 1926, League of Nations Health Organization, Geneva.
48. Meyer KF Pneumonic plague. Bacteriol Rev 1961, 25:249-261.
49. Alsofrom DJ, Mettler FA, Mann JM Radiographic manifestations of plague in New Mexico, 1975-1980: a review of 42 proved cases. Radiology 1981, 139:561-565.
50. Burmeister R Laboratory-acquired pneumonic plague. Ann Intern Med 1962, 56:789-800.
51. Siegel JD, Rhinehart E, Jackson M, et al. 2007 Guidelines for Isolation Precautions: Preventing Trans-mission of Infectious Agents in Health Care Settings Available at the Healthcare Infection Control Practices Advisory Committee, Accessed November 1, 2012. http://www.cdc.gov/hicpac/2007ip/2007isolationprecautions.html.
52. Kool JL Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis 2005, 40:1166-1172.
53. Centers for Disease Control and Prevention Emergency Preparedness and Response. The Laboratory Response Network Available at, Accessed November 18, 2012. http://www.bt.cdc.gov/lrn.
54. American Society of Microbiology Sentinel Level Clinical Microbiology Laboratory Guidelines Available at, Accessed December 1, 2012. http://www.asm.org/index.php/guidelines/sentinel-guidelines.
55. Loiez C, Herwegh S, Wallet F, et al. Detection of Yersinia pestis in sputum by real-time PCR. J Clin Microbiol 2003, 41:4873-4875.
56. Tourdjman M, Ibraheem M, Brett M, et al. Misidentification of Yersinia pestis by automated systems, resulting in delayed diagnoses of human plague infections-Oregon and New Mexico, 2010-2011. Clin Infect Dis 2012, 55:e58-e60.
57. Butler T, Hudson BW The serological response to Yersinia pestis infection. Bull World Health Organ 1977, 55:39-42.
58. Chanteau S, Rahalison L, Ralafiarisoa L, et al. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet 2003, 361:211-216.
59. Galimand M, Carniel E, Courvalin P Resistance of Yersinia pestis to antimicrobial agents. Antimicrob Agents Chemother 2006, 50:3233-3236.
60. Byrne WR, Welkos SL, Pitt ML, et al. Antibiotic treatment of experimental pneumonic plague in mice. Antimicrob Agents Chemother 1998, 42:675-681.
61. Wong JD, Barash JR, Sandfort RF, et al. Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents. Antimicrob Agents Chemother 2000, 44:1995-1996.
62. Crook LD, Tempest B Plague-a clinical review of 27 cases. Arch Intern Med 1992, 152:1253-1256.
63. Welty TK, Grabman J, Kompare E, et al. Nineteen cases of plague in Arizona: a spectrum including ecthyma gangrenosum due to plague and plague in pregnancy. West J Med 1985, 142:641-646.
64. Boulanger L, Ettestad P, Fogarty J, et al. Gentamicin and tetracyclines for the treatment of human plague: a review of 75 cases in New Mexico from 1985-1999. Clin Infect Dis 2004, 38:663-669.
65. Mwengee W, Butler T, Mgema S, et al. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis 2006, 42:614-621.
66. Cunha BA Doxycycline for community-acquired pneumonia. Clin Infect Dis 2003, 37:870.
67. Frean J, Klugman KP, Arntzen L, et al. Susceptibility of Yersinia pestis to novel and conventional antimicrobial agents. J Antimicrob Chemother 2003, 52:294-296.
68. Hernandez E, Girardet M, Ramisse F, et al. Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 anti-microbial agents. J Antimicrob Chemother 2003, 52:1029-1031.
69. Steward J, Lever MS, Russell P, et al. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis. Int J Antimicrob Agents 2004, 24:609-612.
70. Peterson JW, Moen ST, Healy D, et al. Protection afforded by fluoroquinolones in animal models of respiratory infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis. Open Microbiol J 2010, 4:34-46.
71. Layton RC, Mega W, McDonald JD, et al. Levofloxacin cures experimental pneumonic plague in African green monkeys. PLoS Negl Trop Dis 2011, 5:e959.
72. Rosenzweig JA, Brackman SM, Kirtley ML, et al. Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin. Antimicrob Agents Chemother 2011, 55:5034-5042.
73. Russell P, Eley SM, Bell DL, et al. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Yersinia pestis infection in mice. J Antimicrob Chemother 1996, 37:769-774.
74. Kuberski T, Robinson L, Schurgin A A case of plague successfully treated with ciprofloxacin and sympathetic blockade for treatment of gangrene. Clin Infect Dis 2003, 36:521-523.
75. Wheeler AP, Gordon RB Treating patients with severe sepsis. N Engl J Med 1999, 340:207-214.
76. Dellinger PR Inflammation and coagulation: implications for the septic patient. Clin Infect Dis 2003, 36:1259-1265.
77. Feodorova VA, Motin VL Plague vaccines: current developments and future perspectives. Emerg Microbes Infect 2012, 1:e36.
78. Centers for Disease Control and Prevention Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996, 45(RR-14):1-15.
79. Titball RW, Williamson ED Second and third generation plague vaccines. Adv Exp Med Biol 2003, 529:397-406.
80. Eyles JE, Williamson ED, Spiers ID, et al. Generation of protective immune responses to plague by mucosal administration of microspore coencapsulated recombinant subunits. J Control Release 2000, 63:191-200.
81. Morris SR Development of a recombinant vaccine against aerosolized plague. Vaccine 2007, 25:3115-3117.
82. Wang D, Jia N, Li P, et al. Protection against lethal subcutaneous challenge of virulent Y. pestis strain 141 using an F1-V subunit vaccine. Sci China C Life Sci 2007, 50:600-604.
83. Williamson ED, Stagg AJ, Eley SM, et al. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague. Vaccine 2007, 25:1142-1148.
84. Hill J, Eyles JE, Elvin SJ, et al. Administration of antibody to the lung protects mice against pneumonic plague. Infect Immun 2006, 74:3068-3070.
85. Taylor VL, Titball RW, Oyston PC Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague. Microbiology 2005, 151:1919-1926.
86. Balada-Llasat JM, Panilaitis B, Kaplan D, et al. Oral inoculation with type III secretion mutants of Yersinia pseudotuberculosis provides protection from oral, intraperitoneal, or intranasal challenge with virulent Yersinia. Vaccine 2007, 25:1526-1533.
87. Ramalingaswami V Psychosocial effects of the 1994 plague outbreak in Surat, India. Mil Med 2001, 166:29-30.
88. World Health Organization Health Aspects of Chemical and Biological Weapons. Report of a WHO Group of Consultants 1970, WHO, Geneva.
89. Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997, 278:399-411.
90. Centers for Disease Control and Prevention Plague Training Module Available at, Accessed December 1, 2012. http://www.bt.cdc.gov/agent/plague/trainingmodule/index.asp.
91. Blank S, Moskin LC, Zucker JR An ounce of prevention is a ton of work: mass antibiotic prophylaxis for anthrax, New York City, 2001. Emerg Infect Dis 2003, 9:615-622.
92. World Health Organization Public Health Response to Biological and Chemical Weapons: WHO Guidance (2004) Available at, Accessed December 1, 2012. http://www.who.int/csr/delibepidemics/biochemguide/en/.
93. Hinckley AF, Biggerstaff BJ, Griffith KS, et al. Transmission dynamics of primary pneumonic plague in the USA. Epidemiol Infect 2012, 140:554-560.
94. Centers for Disease Control and Prevention Emergency Preparedness and Response. Bioterrorism Available at, Accessed December 1, 2012. http://www.bt.cdc.gov/bioterrorism.
95. English JF Overview of bioterrorism readiness plan: a template for health care facilities. Am J Infect Control 1999, 27:468-469.
96. U.S.Department of Labor: Occupational Safety & Health Administration.Plague Controls Accessed November 1, 2012. http://www.osha.gov/SLTC/plague/controls.html.
97. Centers for Disease Control and Prevention, National Institutes of Health Biosafety in Microbiological and Biomedical Laboratories 1999, U.S. Government Printing Office, Atlanta. 4th ed.
98. Eisen RJ, Petersen JM, Higgins CL, et al. Persistence of Yersinia pestis in soil under natural conditions. Emerg Infect Dis 2008, 14:941-943.
99. Filipkowska Z Sanitary and bacteriological aspects of sewage treatment. Acta Microbiol Pol 2003, 52(suppl):57-66.
100. Bottone EJ Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 1997, 10:257-276.
101. Smego RA, Frean J, Koornhof HJ Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis 1999, 18:1-15.
102. Bottone EJ Yersinia enterocolitica: overview and epidemiologic correlates. Microbes Infect 1999, 1:323-333.
103. Galindo CL, Rosenzweig JA, Kirtley ML, et al. Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in human yersiniosis. J Pathog 2011, 2011:182051.
104. Cantinieaux B, Boelaert J, Hariga C, et al. Impaired neutrophil defense against Yersinia enterocolitica in patients with iron overload who are undergoing dialysis. J Lab Clin Med 1988, 111:524-528.
105. Ong KL, Gould LH, Chen DL, et al. Changing epidemiology of Yersinia enterocolitica infections: markedly decreased rates in young black children. Foodborne Diseases Active Surveillance Network (FoodNet), 1996-2009. Clin Infect Dis 2012, 54(suppl 5):S385-S390.
106. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011, 17:7-15.
107. Helms M, Simonsen J, Molbak K Foodborne bacterial infection and hospitalization: a registry-based study. Clin Infect Dis 2006, 42:498-506.
108. Rosner BM, Stark K, Werber D Epidemiology of reported Yersinia enterocolitica infections in Germany, 2001-2008. BMC Public Health 2010, 10:337.
109. Carniel E, Butler T, Hossain S, et al. Infrequent detection of Yersinia enterocolitica in childhood diarrhea in Bangladesh. Am J Trop Med Hyg 1986, 35:370-371.
110. Tauxe RV, Vandepitte J, Wauters G, et al. Yersinia enterocolitica infections and pork: the missing link. Lancet 1987, 1:1129-1132.
111. Drummond N, Murphy BP, Ringwood T, et al. Yersinia enterocolitica: a brief review of the issues relating to the zoonotic pathogen, public health challenges, and the pork production chain. Foodborne Pathog Dis 2012, 9:179-189.
112. Merilahti-Palo R, Lahesmaa R, Granfors K, et al. Risk of Yersinia infection among butchers. Scand J Infect Dis 1991, 23:55-61.
113. Lee LA, Taylor J, Carter GP, et al. Yersinia enterocolitica 0:3: an emerging cause of pediatric gastroenteritis in the United States. J Infect Dis 1991, 163:660-663.
114. Ackers ML, Schoenfeld S, Markman J, et al. An outbreak of Yersinia enterocolitica O:8 infections associated with pasteurized milk. J Infect Dis 2000, 181:1834-1837.
115. Jones TF, Buckingham SC, Bopp CA, et al. From pig to pacifier: chitterling-associated yersiniosis outbreak among black infants. Emerg Infect Dis 2003, 9:1007-1009.
116. Batz MB, Hoffmann S, Morris JG Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation. J Food Protect 2012, 75(7):1278-1291.
117. MacDonald E, Heier BT, Nygård K, et al. Yersinia enterocolitica outbreak associated with ready-to-eat salad mix, Norway, 2011. Emerg Infect Dis 2012, 18:1496-1499.
118. Abdel-Haq NM, Asmar BI, Abuhammour WM, et al. Yersinia enterocolitica infection in children. Pediatr Infect Dis J 2000, 19:945-948.
119. Adamkiewicz TV, Berkovitch M, Krishnan C, et al. Infection due to Yersinia enterocolitica in a series of patients with beta-thalassemia: incidence and predisposing factors. Clin Infect Dis 1998, 27:1362-1366.
120. Robins-Browne RM, Prpic JK Desferrioxamine and systemic yersiniosis. Lancet 1983, 2:1372.
121. Centers for Disease Control and Prevention Red blood cell transfusions contaminated with Yersinia enterocolitica-United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions. MMWR Morb Mortal Wkly Rep 1997, 46:553-555.
122. Guinet F, Carniel E, Leclercq A Transfusion transmitted Yersinia enterocolitica sepsis. Clin Infect Dis 2011, 53:538-591.
123. Vincent P, Leclercq A, Martin L, et al. Sudden onset of pseudotuberculosis in humans, France, 2004-05. Emerg Infect Dis 2008, 14:1119-1122. Yersinia Surveillance Network.
124. Tsubokura M, Otsuki K, Sato K, et al. Special features of distribution of Yersinia pseudotuberculosis in Japan. J Clin Microbiol 1989, 27:790-791.
125. Tseneva GY, Chesnokova MV, Timofeevich KV, et al. Pseudotuberculosis in the Russian federation. Adv Exp Med Biol 2012, 954:63-68.
126. Long C, Jones TF, Vugia DJ, et al. Yersinia pseudotuberculosis and Y. enterocolitica infections, FoodNet, 1996-2007. Emerg Infect Dis 2010, 16:566-567.
127. Press N, Fyfe M, Bowie W, et al. Clinical and microbiological follow-up of an outbreak of Yersinia pseudotuberculosis serotype Ib. Scand J Infect Dis 2001, 33:523-526.
128. Nuorti JP, Niskanen T, Hallanvuo S, et al. A widespread outbreak of Yersinia pseudotuberculosis O:3 infection from iceberg lettuce. J Infect Dis 2004, 189:766-774.
129. Rimhanen-Finne R, Niskanen T, Hallanvuo S, et al. Yersinia pseudotuberculosis causing a large outbreak associated with carrots in Finland, 2006. Epidemiol Infect 2008, 1-6.
130. Bradford WD, Noce PS, Gutman LT Pathologic features of enteric infection with Yersinia enterocolitica. Arch Pathol 1974, 98:17-22.
131. Townes JM, Deodhar AA, Laine ES, et al. Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study. Ann Rheum Dis 2008, 67:1689-1696.
132. van der Heijden IM, Res PCM, Wilbrink B, et al. Yersinia enterocolitica: a cause of chronic polyarthritis. Clin Infect Dis 1997, 25:831-837.
133. Stuart PM, Woodward JG Yersinia enterocolitica produces superantigenic activity. J Immunol 1992, 148:225-233.
134. Strom H, Johansson C Appendicitis followed by reactive arthritis in an HLA B27-positive man after infection with Yersinia enterocolitica, diagnosed by serotype specific antibodies and antibodies to Yersinia outer membrane proteins. Infection 1997, 25:317-319.
135. Borg AA, Gray J, Dawes PT Yersinia-related arthritis in the United Kingdom: a report of 12 cases and review of the literature. Q J Med 1992, 304:575-582.
136. Granfors K, Jalkanen S, von Essen R, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989, 320:216-221.
137. Rose FB, Camp CJ, Antes EJ Family outbreak of fatal Yersinia enterocolitica pharyngitis. Am J Med 1987, 82:636-637.
138. Greene JN, Herndon P, Nadler JP, et al. Case report: Yersinia enterocolitica necrotizing pneumonia in an immunocompromised patient. Am J Med Sci 1993, 305:171-173.
139. Weber J, Finlayson NB, Mark JB Mesenteric lymphadenitis and terminal ileitis due to Yersinia pseudotuberculosis. N Engl J Med 1970, 283:172-174.
140. Kaasch AJ, Dinter J, Goeser T, et al. Yersinia pseudotuberculosis bloodstream infection and septic arthritis: a case report and review of the literature. Infection 2012, 40:185-190.
141. Eppinger M, Rosovitz MJ, Fricke WF, et al. The complete genome sequence of Yersinia pseudotuberculosis IP31758, the causative agent of Far East scarlet-like fever. PLoS Genet 2007, 3:e142.
142. Uchiyama T, Kato H The pathogenesis of Kawasaki disease and superantigens. Jpn J Infect Dis 1999, 52:141-145.
143. Vincent P, Salo E, Skurnik M, et al. Similarities of Kawasaki disease and Yersinia pseudotuberculosis infection epidemiology. Pediatr Infect Dis J 2007, 26:629-631.
144. Tahara M, Baba K, Waki K, et al. Analysis of Kawasaki disease showing elevated antibody titres of Yersinia pseudotuberculosis. Acta Paediatr 2006, 95:1661-1664.
145. Kachoris M, Ruoff KL, Welch K, et al. Routine culture of stool specimens for Yersinia enterocolitica is not a cost-effective procedure. J Clin Microbiol 1988, 26:582-583.
146. Gayraud M, Scavizzi MR, Mollaret HH, et al. Antibiotic treatment of Yersinia enterocolitica septicemia: a retrospective review of 43 cases. Clin Infect Dis 1993, 17:405-410.
147. Crowe M, Ashford K, Ispahani P Clinical features and antibiotic treatment of septic arthritis and osteomyelitis due to Yersinia enterocolitica. J Med Microbiol 1996, 45:302-309.
148. Perry RD, Fetherston JD Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 1997, 10:35-66.
149. McGovern T, Friedlander A Plague. Textbook of Military Medicine. Part I 1997, 479-502. Office of the Surgeon General, United States Army, Falls Church, VA. F. Sidell, E. Takafuji, D. Franz (Eds.).
150. McNeill WH Plague and Peoples 1998, Anchor Press, Garden City, NY.
151. Drancourt M, Houhamdi L, Raoult D Yersinia pestis as a telluric, human ectoparasite-borne organism. Lancet Infect Dis 2006, 6:234-241.
152. Eisen RJ, Bearden SW, Wilder AP, et al. Early-phase transmission of Yersinia pestis by unblocked fleas as a mechanism explaining rapidly spreading plague epizootics. Proc Natl Acad Sci U S A 2006, 103:15380-15385.
153. Stenseth NC, Atshabar BB, Begon M, et al. Plague: past, present, and future. PLoS Med 2008, 5:e3.
154. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. JAMA 2000, 283:2281-2290.
155. Centers for Disease Control and Prevention and the Animal Plant Health Inspection Agency National Select Agent Registry Available at, Accessed January 15, 2013. http://www.selectagents.gov.
156. U.S.Department of Health and Human Services 42 CFR Part 73. Possession, use, and transfer of select agents and toxins; biennial review. Fed Register 2012, 77:194.
157. Centers for Disease Control and Prevention, National Center for Infectious Diseases Division of Vector-Borne Infectious Diseases, World Health Organization, World Health Organization. Division of Emerging and Other Communicable Diseases Surveillance and Control. Laboratory Manual of Plague Diagnostic Tests 2000, Centers for Disease Control and Prevention, Atlanta, GA.
158. Achtman M, Zurth K, Morelli G, et al. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A 1999, 24:14043-14048.
159. Parkhill J, Wren BW, Thompson NR, et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 2001, 413:523-527.
160. Hinnebusch BJ The evolution of flea-borne transmission in Yersinia pestis. Curr Issues Mol Biol 2005, 7:197-212.
161. Fabrega A, Vila J Yersinia enterocolitica: pathogenesis, virulence, and antimicrobial resistance. Enferm Infecc Microbiol Clin 2012, 30:24-32.
162. Achtman M, Morelli G, Zhu P, et al. Microevolution and history of the plague bacillus, Yersinia pestis. Proc Natl Acad Sci U S A 2004, 101:17.
163. Gage KL Plague surveillance. Plague Manual: Epidemiology, Distribution, Surveillance and Control 1999, 135-166. World Health Organization, Geneva.
164. World Health Organization Human plague in 2002 and 2003. Wkly Epidemiol Rec 2004, 79:301-306.
165. Boisier P, Rahalison L, Rasolomaharo M, et al. Epidemiological features of four successive annual outbreaks of bubonic plague in Mahajanga, Madagascar. Emerg Infect Dis 2002, 8:311-316.
166. Eisen RJ, Gage KL Adaptive strategies of Yersinia pestis to persist during inter-epizootic and epizootic periods. Vet Res 2009, 40:01.
167. von Reyn CF, Barnes AM, Weber NS, et al. Bubonic plague from exposure to a rabbit: a documented case, and a review of rabbit-associated plague cases in the United States. Am J Epidemiol 1976, 104:81-87.
168. Gage KL, Dennis DT, Orloski KA, et al. Cases of cat-associated plague in the western U.S., 1977-1998. Clin Infect Dis 2000, 30:893-900.
169. Gould LH, Pape J, Ettestad P, et al. Dog-associated risk factors for human plague. Zoonoses Public Health 2008, 55:448-454.
170. Centers for Disease Control and Prevention Imported plague-New York City, 2002. MMWR Morb Mortal Wkly Rep 2003, 52:725-728.
171. Wong D, Wild MA, Walburger MA, et al. Primary pneumonic plague contracted from a mountain lion carcass. Clin Infect Dis 2009, 49:e33-e38.
172. Centers for Disease Control and Prevention Fatal laboratory-acquired infection with an attenuated Yersinia pestis strain-Chicago, Illinois, 2009. MMWR Morb Mortal Wkly Rep 2011, 60:201-205.
173. Quenee LE, Hermanas TM, Ciletti N, et al. Hereditary hemochromatosis restores the virulence of plague vaccine strains. J Infect Dis 2012, 206:1050-1058.
174. Butler T A clinical study of bubonic plague: observations on the 1970 Vietnam epidemic with emphasis on coagulation studies, skin histology and electrocardiograms. Am J Med 1972, 53:268-276.
175. Butler T, Bell WR, Nguyen NL, et al. Yersinia pestis infection in Vietnam, I. Clinical and hematological aspects. J Infect Dis 1974, 129(suppl):S78-S84.
176. Hull HF, Montes JM, Mann JM Septicemic plague in New Mexico. J Infect Dis 1987, 155:113-118.
177. Crook LD, Tempest B Plague: a clinical review of 27 cases. Arch Intern Med 1992, 152:1253-1256.
178. Alsofrom DJ, Mettler FA, Mann JM Radiographic manifestations of plague in New Mexico, 1975-1980: a review of 42 proved cases. Radiology 1981, 139:561-565.
179. Burmeister R Laboratory-acquired pneumonic plague. Ann Intern Med 1962, 56:789-800.
180. Siegel JD, Rhinehart E, Jackson M, et al. 2007 Guidelines for Isolation Precautions: Preventing Trans-mission of Infectious Agents in Health Care Settings Available at the Healthcare Infection Control Practices Advisory Committee, Accessed November 1, 2012. http://www.cdc.gov/hicpac/2007ip/2007isolationprecautions.html.
181. Kool JL Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis 2005, 40:1166-1172.
182. Centers for Disease Control and Prevention Emergency Preparedness and Response. The Laboratory Response Network Available at, Accessed November 18, 2012. http://www.bt.cdc.gov/lrn.
183. American Society of Microbiology Sentinel Level Clinical Microbiology Laboratory Guidelines Available at, Accessed December 1, 2012. http://www.asm.org/index.php/guidelines/sentinel-guidelines.
184. Tourdjman M, Ibraheem M, Brett M, et al. Misidentification of Yersinia pestis by automated systems, resulting in delayed diagnoses of human plague infections-Oregon and New Mexico, 2010-2011. Clin Infect Dis 2012, 55:e58-e60.
185. Galimand M, Carniel E, Courvalin P Resistance of Yersinia pestis to antimicrobial agents. Antimicrob Agents Chemother 2006, 50:3233-3236.
186. Crook LD, Tempest B Plague-a clinical review of 27 cases. Arch Intern Med 1992, 152:1253-1256.
187. Boulanger L, Ettestad P, Fogarty J, et al. Gentamicin and tetracyclines for the treatment of human plague: a review of 75 cases in New Mexico from 1985-1999. Clin Infect Dis 2004, 38:663-669.
188. Mwengee W, Butler T, Mgema S, et al. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis 2006, 42:614-621.
189. Hernandez E, Girardet M, Ramisse F, et al. Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents. J Antimicrob Chemother 2003, 52:1029-1031.
190. Layton RC, Mega W, McDonald JD, et al. Levofloxacin cures experimental pneumonic plague in African green monkeys. PLoS Negl Trop Dis 2011, 5:e959.
191. Kuberski T, Robinson L, Schurgin A A case of plague successfully treated with ciprofloxacin and sympathetic blockade for treatment of gangrene. Clin Infect Dis 2003, 36:521-523.
192. Feodorova VA, Motin VL Plague vaccines: current developments and future perspectives. Emerg Microbes Infect 2012, 1:e36.
193. Centers for Disease Control and Prevention Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996, 45(RR-14):1-15.
194. Ramalingaswami V Psychosocial effects of the 1994 plague outbreak in Surat, India. Mil Med 2001, 166:29-30.
195. World Health Organization Health Aspects of Chemical and Biological Weapons. Report of a WHO Group of Consultants 1970, WHO, Geneva.
196. Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997, 278:399-411.
197. Centers for Disease Control and Prevention Plague Training Module Available at, Accessed December 1, 2012. http://www.bt.cdc.gov/agent/plague/trainingmodule/index.asp.
198. Blank S, Moskin LC, Zucker JR An ounce of prevention is a ton of work: mass antibiotic prophylaxis for anthrax, New York City, 2001. Emerg Infect Dis 2003, 9:615-622.
199. World Health Organization Public Health Response to Biological and Chemical Weapons: WHO Guidance (2004) Available at, Accessed December 1, 2012. http://www.who.int/csr/delibepidemics/biochemguide/en/.
200. Hinckley AF, Biggerstaff BJ, Griffith KS, et al. Transmission dynamics of primary pneumonic plague in the USA. Epidemiol Infect 2012, 140:554-560.
201. Centers for Disease Control and Prevention Emergency Preparedness and Response. Bioterrorism Available at, Accessed December 1, 2012. http://www.bt.cdc.gov/bioterrorism.
202. English JF Overview of bioterrorism readiness plan: a template for health care facilities. Am J Infect Control 1999, 27:468-469.
203. U.S.Department of Labor: Occupational Safety & Health Administration Plague Controls Accessed November 1, 2012. http://www.osha.gov/SLTC/plague/controls.html.
204. Centers for Disease Control and Prevention, National Institutes of Health Biosafety in Microbiological and Biomedical Laboratories 1999, U.S. Government Printing Office, Atlanta. 4th ed.
205. Bottone EJ Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev 1997, 10:257-276.
206. Smego RA, Frean J, Koornhof HJ Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis 1999, 18:1-15.
207. Bottone EJ Yersinia enterocolitica: overview and epidemiologic correlates. Microbes Infect 1999, 1:323-333.
208. Galindo CL, Rosenzweig JA, Kirtley ML, et al. Pathogenesis of Y. enterocolitica and Y. pseudotuberculosis in human yersiniosis. J Pathog 2011, 2011:182051.
209. Ong KL, Gould LH, Chen DL, et al. Changing epidemiology of Yersinia enterocolitica infections: markedly decreased rates in young black children. Foodborne Diseases Active Surveillance Network (FoodNet), 1996-2009. Clin Infect Dis 2012, 54(suppl 5):S385-S390.
210. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011, 17:7-15.
211. Tauxe RV, Vandepitte J, Wauters G, et al. Yersinia enterocolitica infections and pork: the missing link. Lancet 1987, 1:1129-1132.
212. Ackers ML, Schoenfeld S, Markman J, et al. An outbreak of Yersinia enterocolitica O:8 infections associated with pasteurized milk. J Infect Dis 2000, 181:1834-1837.
213. Jones TF, Buckingham SC, Bopp CA, et al. From pig to pacifier: chitterling-associated yersiniosis outbreak among black infants. Emerg Infect Dis 2003, 9:1007-1009.
214. MacDonald E, Heier BT, Nygård K, et al. Yersinia enterocolitica outbreak associated with ready-to-eat salad mix, Norway, 2011. Emerg Infect Dis 2012, 18:1496-1499.
215. Centers for Disease Control and Prevention Red blood cell transfusions contaminated with Yersinia enterocolitica-United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions. MMWR Morb Mortal Wkly Rep 1997, 46:553-555.
216. Guinet F, Carniel E, Leclercq A Transfusion transmitted Yersinia enterocolitica sepsis. Clin Infect Dis 2011, 53:538-591.
217. Long C, Jones TF, Vugia DJ, et al. Yersinia pseudotuberculosis and Y. enterocolitica infections, FoodNet, 1996-2007. Emerg Infect Dis 2010, 16:566-567.
218. Nuorti JP, Niskanen T, Hallanvuo S, et al. A widespread outbreak of Yersinia pseudotuberculosis O:3 infection from iceberg lettuce. J Infect Dis 2004, 189:766-774.
219. Townes JM, Deodhar AA, Laine ES, et al. Reactive arthritis following culture-confirmed infections with bacterial enteric pathogens in Minnesota and Oregon: a population-based study. Ann Rheum Dis 2008, 67:1689-1696.
220. van der Heijden IM, Res PCM, Wilbrink B, et al. Yersinia enterocolitica: a cause of chronic polyarthritis. Clin Infect Dis 1997, 25:831-837.
221. Stuart PM, Woodward JG Yersinia enterocolitica produces superantigenic activity. J Immunol 1992, 148:225-233.
222. Rose FB, Camp CJ, Antes EJ Family outbreak of fatal Yersinia enterocolitica pharyngitis. Am J Med 1987, 82:636-637.
223. Greene JN, Herndon P, Nadler JP, et al. Case report: Yersinia enterocolitica necrotizing pneumonia in an immunocompromised patient. Am J Med Sci 1993, 305:171-173.
224. Kaasch AJ, Dinter J, Goeser T, et al. Yersinia pseudotuberculosis bloodstream infection and septic arthritis: a case report and review of the literature. Infection 2012, 40:185-190.
225. Vincent P, Salo E, Skurnik M, et al. Similarities of Kawasaki disease and Yersinia pseudotuberculosis infection epidemiology. Pediatr Infect Dis J 2007, 26:629-631.
226. Gayraud M, Scavizzi MR, Mollaret HH, et al. Antibiotic treatment of Yersinia enterocolitica septicemia: a retrospective review of 43 cases. Clin Infect Dis 1993, 17:405-410.